The tumor suppressor Wnt inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomas.
about
Promoter methylation inhibits BRD7 expression in human nasopharyngeal carcinoma cells.Epigenetic disruption of cell signaling in nasopharyngeal carcinoma.Site-specific molecular signatures predict aggressive disease in HNSCC.Epigenetic identification of ADAMTS18 as a novel 16q23.1 tumor suppressor frequently silenced in esophageal, nasopharyngeal and multiple other carcinomas.Epigenetic markers for early detection of nasopharyngeal carcinoma in a high risk population.Dickkopf-related protein 2 induces G0/G1 arrest and apoptosis through suppressing Wnt/β-catenin signaling and is frequently methylated in breast cancer.Global hypomethylation and promoter methylation in small intestinal neuroendocrine tumors: an in vivo and in vitro study.Association of Wnt1/beta-catenin with clinical pathological characteristics and prognosis of esophageal squamous cell carcinomaEpigenetic silencing of the WNT antagonist Dickkopf 3 disrupts normal Wnt/β-catenin signalling and apoptosis regulation in breast cancer cellsSilencing of hypoxia-inducible tumor suppressor lysyl oxidase gene by promoter methylation activates carbonic anhydrase IX in nasopharyngeal carcinoma.Comparative gene-expression analysis of the dental follicle and periodontal ligament in humans.The Wnt inhibitory factor 1 (WIF1) is targeted in glioblastoma and has a tumor suppressing function potentially by induction of senescenceKlotho is silenced through promoter hypermethylation in gastric cancer.WIF1 is a frequent target for epigenetic silencing in squamous cell carcinoma of the cervixTherapeutic targeting of CBP/β-catenin signaling reduces cancer stem-like population and synergistically suppresses growth of EBV-positive nasopharyngeal carcinoma cells with cisplatin.Deregulation of secreted frizzled-related proteins is associated with aberrant β-catenin activation in the carcinogenesis of oral submucous fibrosis.Molecular mechanisms of ethanol-associated oro-esophageal squamous cell carcinoma.Rescued expression of WIF-1 in gallbladder cancer inhibits tumor growth and induces tumor cell apoptosis with altered expression of proteins.WIF1 causes dysfunction of heart in transgenic mice.Promoter methylation of tumor suppressor genes in esophageal squamous cell carcinoma.Novel systemic therapeutic for nasopharyngeal carcinoma.Pathways involved in Drosophila and human cancer development: the Notch, Hedgehog, Wingless, Runt, and Trithorax pathway.Role of DNA methylation in head and neck cancer.Refining the role for adult stem cells as cancer cells of originThe interplay of host genetic factors and Epstein-Barr virus in the development of nasopharyngeal carcinoma.Wnt/β-catenin signaling plays an ever-expanding role in stem cell self-renewal, tumorigenesis and cancer chemoresistance.Characterization of the nasopharyngeal carcinoma methylome identifies aberrant disruption of key signaling pathways and methylated tumor suppressor genes.Epigenetic markers for noninvasive early detection of nasopharyngeal carcinoma by methylation-sensitive high resolution melting.Frequent hypermethylation of WNT pathway genes in laryngeal squamous cell carcinomas.Epigenetic alteration of the Wnt inhibitory factor-1 promoter is common and occurs in advanced stage of Tunisian nasopharyngeal carcinoma.HOTAIR, a prognostic factor in esophageal squamous cell carcinoma, inhibits WIF-1 expression and activates Wnt pathway.Epigenetic approach for angiostatic therapy: promising combinations for cancer treatment.Identification of a lncRNA involved functional module for esophageal cancer subtypes.Transcriptional regulation of Wnt inhibitory factor-1 by Miz-1/c-Myc.The effect of EBV on WIF1, NLK, and APC gene methylation and expression in gastric carcinoma and nasopharyngeal cancer.Gene and miRNA expression changes in squamous cell carcinoma of larynx and hypopharynx.Notch receptor inhibition reveals the importance of cyclin D1 and Wnt signaling in invasive esophageal squamous cell carcinoma.Correlations of Promoter Methylation in WIF-1, RASSF1A, and CDH13 Genes with the Risk and Prognosis of Esophageal Cancer.DNA Methylation and the HOXC6 Paradox in Prostate Cancer.Possible new targets for GPCR modulation: allosteric interactions, plasma membrane domains, intercellular transfer and epigenetic mechanisms.
P2860
Q33367808-4038F83A-FA06-488E-84AD-949094B6E48BQ33579472-700852BC-81BF-432F-BE6F-973910F8F50FQ33595033-169C5486-772C-4938-BB0E-DBFD5FBA842EQ33874587-A902C23D-CA65-4DEB-8204-74C4A65D4B37Q33887581-8AD040B0-7E75-43F9-A015-3923FE1ED498Q33889229-7615483D-59A3-4AF0-B186-B47CE7C89193Q34084289-58A741A2-4879-4CAC-8CAC-27288FF84358Q34112144-47917129-2E24-4567-967E-85A9F90303F1Q34154767-EE1998D6-625D-48EA-9706-1FE329C2348AQ34704924-87890E19-80ED-4DC4-B027-8A31E6067B16Q35078351-9C818E9D-4A74-4605-B019-BD2D8F363237Q35085317-DE309EA2-F87B-449E-AFD2-127264216C6FQ35232389-D4560417-BA7C-439C-A351-93B3830ACBF9Q35479045-69A7388E-1E2A-441B-84CD-DDA2D10E2E68Q35505126-3A8D41C1-AB8F-4EA0-BEEF-93D08C78EAF8Q36176784-14713A7A-0944-4A07-AF24-8A5F27E777B8Q36612435-DBCFEC1A-8112-4123-B6EA-2B55E195589FQ37190811-987D331A-7C38-40B3-BC74-4E109467CDA2Q37330742-DB0E8610-14CE-419A-BCB9-FEA4DD5F028CQ37354050-1EF50940-ACFA-403F-9F3B-12E591E75E39Q37982126-EA7F3191-4E0E-4E5B-85A4-F17C9F9378F8Q37993742-1C363BE5-5CAD-4D89-AB59-EC109F4CDC75Q38019157-B851DA8A-08BE-42B9-A45C-454A0C17A402Q38252977-EC6D8BA6-A32D-4BA3-AE60-6525B0576D28Q38264787-215FD9E9-D0DA-4E2A-A0AE-1411E2C73A9EQ38807957-1F667977-9487-44C6-9A1C-2283BB8110EDQ38931940-EFF201C2-C52D-4F82-BDDE-A2293B76A633Q38959017-BE2E2795-DD34-49C9-8B3B-C0D650A0D48AQ39001461-8C028FBD-C21D-4B2B-BA57-CD4E7E34938FQ39001870-8D123D81-58A0-48F5-A62C-7AB3B95E295EQ39080607-D29B9D93-3990-45CA-96E5-1748CAF1C242Q39220891-C9A5B8B4-7542-49B9-85A7-3E6CF02D700DQ39476144-1144C7C3-6A6C-4B33-A92F-0B7D3874E354Q39583166-FEFF9B0A-FF63-43FD-9169-776E5B60F75DQ40185896-4A8D5F1B-722B-4027-A73A-A47167B47980Q40492891-23453DBC-7CEC-4B7C-AAE9-21120B5FB099Q42028034-B1B658BF-FBA4-4458-AB26-D16712807B30Q42034570-213B4AC6-738F-439C-8638-AA9E7E0692D3Q42585509-59410A1B-E60E-4FF7-9B56-E3F983B101A1Q46065953-C90DFE6C-7A14-44DC-AC1E-5891ACADD7F1
P2860
The tumor suppressor Wnt inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomas.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
The tumor suppressor Wnt inhib ...... eal and esophageal carcinomas.
@ast
The tumor suppressor Wnt inhib ...... eal and esophageal carcinomas.
@en
The tumor suppressor Wnt inhib ...... eal and esophageal carcinomas.
@nl
type
label
The tumor suppressor Wnt inhib ...... eal and esophageal carcinomas.
@ast
The tumor suppressor Wnt inhib ...... eal and esophageal carcinomas.
@en
The tumor suppressor Wnt inhib ...... eal and esophageal carcinomas.
@nl
prefLabel
The tumor suppressor Wnt inhib ...... eal and esophageal carcinomas.
@ast
The tumor suppressor Wnt inhib ...... eal and esophageal carcinomas.
@en
The tumor suppressor Wnt inhib ...... eal and esophageal carcinomas.
@nl
P2093
P50
P1476
The tumor suppressor Wnt inhib ...... geal and esophageal carcinomas
@en
P2093
Andrew van Hasselt
Anthony T C Chan
George S W Tsao
Gopesh Srivastava
Kwan Y Lee
Sheng Zhong
Stephen L Chan
Yajun Wang
P2860
P2888
P304
P356
10.1038/LABINVEST.3700547
P577
2007-03-26T00:00:00Z
P5875
P6179
1019983752